Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New CEO at Polyplus-transfection

This article was originally published in Scrip

Executive Summary

Polyplus-transfection (France), a privately held company developing solutions for molecular and cellular biology, today has appointed Mark Bloomfield CEO. He succeeds Frédéric Perraud, who continues as chief operating officer and deputy CEO. Mr Bloomfield has more than 15 years' senior sales, commercial leadership and business management experience with companies working in biotechnology tools and analytical instruments.






Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts